Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CareDx, Inc.CDNA · Entity 4344 | Director · President and CEO | October 01, 2026 | October 05, 2026 |
| VERACYTE, INC.VCYT · Entity 2018 | Chief Commercial Officer | December 02, 2020 | December 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CareDx, Inc.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 644,937 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Tax withholding · Disposed 8,511 · Balance 644,937 F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units.
VERACYTE, INC.
Report date December 02, 2020 · Filed December 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,844 |
Reported balance
After 2020-12-02 transaction · row 1
1 source rowRow 1 · 2020-12-02 · Tax withholding · Disposed 465 · Balance 73,844 F1: The reporting person is reporting the withholding of 217 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively and does not represent a sale by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person is reporting the withholding of 217 and 248 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively and does not represent a sale by the reporting person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 53 | $0.00 Strike: $4.00 | $0.00 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · derivative · entry 9 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53 shares Expires 2023-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 473 | $33.78 | $15,976.14 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 8 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,634 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $33.77 to $33.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 55,970 | $33.37 | $1,867,573.38 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 7 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,107 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.72 to $33.71. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,844 | $5.98 | $58,867.12 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 6 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,077 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,375 | $9.05 | $84,843.75 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 5 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 19,336 | $6.45 | $124,717.20 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,835 | $8.86 | $78,278.10 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,522 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,000 | $14.34 | $129,060.00 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 31, 2020 Filed Sep 1, 2020 21:08 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 53 | $4.00 | $212.00 |
DisclosureSEC source: 0001437749-20-019131 · rdgdoc.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,687 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 11, 2020. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,400 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-018681 · rdgdoc.xml · derivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,837 Underlying: Common Stock · 1,400 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 1,400 | $36.00 | $50,405.46 |
DisclosureSEC source: 0001437749-20-018681 · rdgdoc.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,634 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.00 to $36.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| August 21, 2020 Filed Aug 25, 2020 21:10 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,400 | $8.86 | $12,404.00 |
DisclosureSEC source: 0001437749-20-018681 · rdgdoc.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 14,095 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001437749-20-016562 · rdgdoc.xml · derivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,237 Underlying: Common Stock · 14,095 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 14,095 | $36.12 | $509,145.23 |
DisclosureSEC source: 0001437749-20-016562 · rdgdoc.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,634 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $36.00 to $36.35. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 31, 2020 Filed Aug 5, 2020 00:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 14,095 | $8.86 | $124,881.70 |
DisclosureSEC source: 0001437749-20-016562 · rdgdoc.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,729 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · balance_after: Includes 110 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 653 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · derivative · entry 6 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 653 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 653 | $32.36 | $21,131.08 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 21, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 653 | $2.40 | $1,567.20 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 11,294 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · derivative · entry 5 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 653 Underlying: Common Stock · 11,294 shares Expires 2021-09-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 11,294 | $32.05 | $361,993.03 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $32.00 to $32.32. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 20, 2020 Filed Jul 22, 2020 22:16 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 11,294 | $2.40 | $27,105.60 |
DisclosureSEC source: 0001437749-20-015556 · rdgdoc.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,818 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 20:07 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 325 | $26.01 | $8,453.25 |
DisclosureSEC source: 0001384101-20-000072 · wf-form4_159130122706539.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,524 F1 · kind: The reporting person is reporting the withholding of 152 and 173 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 and 500 Restricted Stock Units, respectively, granted on March 2, 2018 and February 28, 2019, respectively and does not represent a sale by the reporting person. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 1,540 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001384101-20-000064 · wf-form4_158940312296863.xml · derivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540 Underlying: Common Stock · 1,540 shares Expires 2030-05-10 F2 · derivative.exercise_date: The stock options awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:52 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000064 · wf-form4_158940312296863.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,849 F1 · kind: Restricted stock units awarded on May 11, 2020 vest 18 months from May 1, 2020 subject to continuing employment of the Reporting Person on the vesting date. Read SEC document |
| March 03, 2020 Filed Mar 3, 2020 22:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 2,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000035 · wf-form4_158327630587282.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,584 F3 · kind: Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes. Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 22:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 997 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000035 · wf-form4_158327630587282.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,472 F3 · kind: Shares relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units. The Reporting Person did not sell or otherwise dispose of the shares for any reason other than to cover required taxes. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $24.69 | $0.00 |
DisclosureSEC source: 0001384101-20-000035 · wf-form4_158327630587282.xml · derivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2030-02-27 F4 · derivative.exercise_date: The option becomes exercisable as to 25% of the shares on February 28, 2021, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 22:58 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-20-000035 · wf-form4_158327630587282.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,469 F1 · kind: Restricted stock units awarded on February 28, 2020 vest 25% on March 2, 2021 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date. F2 · balance_after: Includes 1,194 shares of common stock purchased pursuant to the Veracyte, Inc. Employee Stock Purchase Plan. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 9,838 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · derivative · entry 6 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,792 Underlying: Common Stock · 9,838 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 9,838 | $30.09 | $295,994.92 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · nonDerivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,275 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.55. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 9,838 | $9.05 | $89,033.90 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,113 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 8,100 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · derivative · entry 5 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,630 Underlying: Common Stock · 8,100 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 3, 2018, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 8,100 | $30.01 | $243,046.98 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,275 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.02. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 21:17 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 8,100 | $9.05 | $73,305.00 |
DisclosureSEC source: 0001384101-19-000162 · wf-form4_157592621292255.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| December 02, 2019 Filed Dec 4, 2019 21:24 UTC | VERACYTE, INC. VCYT · Entity 2018 | Tax withholdingCommon Stock | 217 | $27.19 | $5,900.23 |
DisclosureSEC source: 0001384101-19-000154 · wf-form4_157549465021571.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,275 F1 · shares: The reporting person is reporting the withholding of 217 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 437 Restricted Stock Units granted on March 2, 2018 and does not represent a sale by the reporting person. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,753 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · derivative · entry 10 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,730 Underlying: Common Stock · 10,753 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 3, 2018 and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 4,744 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · derivative · entry 9 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,332 Underlying: Common Stock · 4,744 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 15,497 | $28.55 | $442,479.64 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 6 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,492 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.50 to $28.81. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,753 | $9.05 | $97,314.65 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 5 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 4,744 | $8.86 | $42,031.84 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,236 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 1,517 | $0.00 Strike: $9.05 | $0.00 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · derivative · entry 8 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,483 Underlying: Common Stock · 1,517 shares Expires 2027-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F5 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 3, 2018 and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 924 | $0.00 Strike: $8.86 | $0.00 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · derivative · entry 7 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,076 Underlying: Common Stock · 924 shares Expires 2025-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 2,441 | $28.52 | $69,609.51 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,492 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.50 to $28.54. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 1,517 | $9.05 | $13,728.85 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,933 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| November 25, 2019 Filed Nov 27, 2019 21:30 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 924 | $8.86 | $8,186.64 |
DisclosureSEC source: 0001384101-19-000142 · wf-form4_157489023384890.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 19,571 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000138 · wf-form4_157420306616176.xml · derivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,338 Underlying: Common Stock · 19,571 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · derivative.exercise_date: The option became exercisable as to 25% of the shares on March 1, 2017, and the remaining shares vest at a rate of 1/48th of the total number of shares subject to the award for each month of continuous service thereafter. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 19,571 | $25.18 | $492,787.99 |
DisclosureSEC source: 0001384101-19-000138 · wf-form4_157420306616176.xml · nonDerivative · entry 2 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,492 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $24.86 to $25.61. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:38 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 19,571 | $6.45 | $126,232.95 |
DisclosureSEC source: 0001384101-19-000138 · wf-form4_157420306616176.xml · nonDerivative · entry 1 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:42 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 16,091 | $0.00 Strike: $6.45 | $0.00 |
DisclosureSEC source: 0001384101-19-000134 · wf-form4_157195688905784.xml · derivative · entry 4 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,909 Underlying: Common Stock · 16,091 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F4 · derivative.exercise_date: The option is fully vested. Read SEC document |
| October 22, 2019 Filed Oct 24, 2019 22:42 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 300 | $28.03 | $8,408.49 |
DisclosureSEC source: 0001384101-19-000134 · wf-form4_157195688905784.xml · nonDerivative · entry 3 Hanna John Walter JR · CIK 0001781127 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,492 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 14, 2019. F3 · price: Represents weighted average sales price. Sale prices for the transactions range from $28.01 to $28.05. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.